FeatureBase (formerly Molecula)
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | <1m | 1.5m | 2.5m | 4.5m | 7.5m | 7.5m |
% growth | - | 200 % | 67 % | 80 % | 67 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Seed | |
$6.0m | Seed | ||
$17.6m | Series A | ||
* | $10.0m Valuation: $88.0m | Series A | |
N/A | Series A | ||
Total Funding | €30.5m |
Related Content
Recent News about FeatureBase (formerly Molecula)
EditMolecula, through its flagship product FeatureBase, operates in the data analytics and artificial intelligence (AI) market. The company provides a feature-oriented database platform designed to power real-time analytics and machine learning applications. FeatureBase is engineered to deliver ultra-low latency, enabling organizations to access and query data in milliseconds, which is crucial for optimizing internet traffic, detecting anomalies, and improving customer experiences. Molecula serves a diverse range of industries including financial services, healthcare, life sciences, public sector, and technology. The business model revolves around offering its database platform as a service, generating revenue through subscription fees and licensing. By closing the gap between data and decision-making, Molecula helps organizations unlock the power of real-time analytics and AI, thereby optimizing business processes and enhancing operational efficiency.
Keywords: real-time analytics, machine learning, ultra-low latency, feature-oriented database, data access, anomaly detection, customer experience, financial services, healthcare, technology.